Aurobindo Pharma Ltd 2018 Annual Report with Sustainability Disclosures
Company: Aurobindo Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2018
Type: Annual Report with Sustainability Disclosures
Pages: 280
The report highlights the company’s 9.3% consolidated revenue growth to ₹164,998 million in FY2017-18, alongside a global workforce of more than 19,000 employees. It describes a fully functional 30 MW captive solar power plant established during the year to reduce the company’s carbon footprint. The company also reports ₹200 million in CSR spending across education, healthcare, water, environmental sustainability, rural development and other community programs.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.